Magnetic stimulation of the brain in animal depression models responsive to ECS

Journal of ECT

Volumn 14, Issue 3, 1998, Pages 194-205

  Belmaker, R H ^a,b   Grisaru, Nimrod ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Animal models; Electroconvulsive shock; Transcranial magnetic stimulation

Indexed keywords

BETA ADRENERGIC RECEPTOR; BRAIN MONOAMINE; DOPAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; DEPRESSION; DOPAMINE BRAIN LEVEL; ELECTROCONVULSIVE THERAPY; IMMOBILIZATION; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; RAT; RECEPTOR DOWN REGULATION; STEREOTYPY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 0031690153     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-199809000-00005     Document Type: Article

References (51)

1. Barker AT. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol 1991;8:26-37.
2. Bates MN. Extremely low frequency electromagnetic fields and cancer: the epidemiological evidence. Environ Health Perspect 1991;95:147-56.
3. Ben-Shachar D, Belmaker RH, Grisaru N, Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm 1997;104:191-7.
4. Blackwood D, Whalley L, Christie J, Blackbaum I, StClair D, McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry 1987;150:154-60.
5. Bolwig TG. The influence of electrically-induced seizures on deep brain structures. In: Lerer B, Weiner RD, Belmaker RH, eds. ECT: basic mechanisms London: John Libbey, 1984:132-8.
6. Brown SA, Gershon S, Dopamine and depression. J Neural Transm 1993;91:75-109.
7. Buchsbaum Md, Delisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1894;4:1159-66.
8. Cantello R, Gianelli M, Bettucci D. Parkinson's disease rigidity: magnetic motor evoked potentials in small hand muscle. Neurology 1991;41:1449-56.
9. 125I]iodocyanopindolol? J Receptor Res 1992;12:369-87.
10. Dunn AJ. Stress-related changes in the cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone. J Neurochem 1988;51:406-12.
11. Ebert MH, Baldessarini RJ, Lipinski JF, Berv K. Effects of electroconvulsive seizures on amine metabolism in the rat brain. Arch Gen Psychiatry 1973;29:397-401.
12. Fleischmann A, Prolov K, Abarbanel J, Belmaker RH. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Res 1995;699:130-2.
13. Fleischmann A, Steppel J, Leon A, Belmaker RH. The effect of transcranial magnetic stimulation compared with electroconvulsive shock on rat apomorphine-induced stereotypy. Eur Neuropsychopharmacol 1994;4:449-50.
14. Fleischmann A, Stemheim A, Etgen AM, Li C, Grisaru N, Belmaker RH. Transcranial magnetic stimulation downregulates β-adrenoreceptors in rat cortex. J Neural Transm 1996;103:1361-6.
15. Fleischmann A, Talpalar AE, Grossman Y, Silverberg D, Belmaker RH. Antidepressant potential of transcranial magnetic stimulation in rat models: comparison of slow versus rapid magnetic stimulation. In: Montgomery S, Halbreich U, eds, Pharmacotherapy of mood and cognition. Washington DC: American Psychiatric Press (in press).
16. George MS, Wassermann EM. Rapid-rate transcranial magnetic stimulation (rTMS) and ECT. Convulsive Ther 1994;10:251-3.
17. George MS, Wasserman EM, Kimbrell TA, Little JT, Williams WE, Greenberg D, Hallet M, Post RM. Daily left prefrontal rTMS improves mood in depression: a placebo-controlled crossover trial. Am J Psychiatry 1997;154:1752-6.
18. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallet M, Post RM. Daily repetitive transcranial magnetic stimulation (rTMS) improves in refractory depression. Neuroreport 1995;6:1853-6.
19. George MS, Wassermann EM, Williams W, Steppel J, Pascual-Leone A, Basser P, Hallet M, Post RM. Changes in mood and hormone levels after rapid rate transcranial magnetic stimulation (rTMS) of prefrontal cortex. J Neuropsychiatry Clin Neurosci 1996;8:172-80.
20. Glue P, Costello MJ, Pert A, Mele A, Nutt DJ. Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology 1990;100:60-5.
21. Graham-Smith DG, Green AR, Costain DW. Mechanism of the antidepressant action of electroconvulsive therapy. Lancet 1978;1:254-6.
22. Green AR, Heal DJ, Vincent ND. The effects of single and repeated electroconvulsive shock administration on the release of 5-hydroxytryptamine and noradrenaline from cortical slices of rat brain. Br J Pharmacol 1987;92:25-30.
23. Grisaru N, Abarbanel JM, Belmaker RH. Slow magnetic stimulation of motor cortex and frontal lobe in depression and schizophrenia. Acta Neuropsychiatr 1995;7:S21-3.
24. Grisaru N, Yaroslavsky U, Abarbanel J, Lamberg T, Belmaker RH. Transcranial magnetic stimulation in depression and schizophrenia. Eur Neuropsychopharmacol 1994;4:287-8.
25. Halbreich U, Lumley LA. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 1993;29:159-73.
26. Hallet M, Cohen LG. Magnetism: a new method for stimulation of nerve and brain. JAMA 1989;262:538-41.
27. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
28. Hoflich G, Kasper S, Hufnagel A, Ruhrmann S, Moller HJ. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression: a report of two cases. Hum Psychopharmacol 1993;8:361-5.
29. Jones SM, Streletz LJ, Raab V. Lower extremity motor evoked potentials in multiple sclerosis. Arch Neurol 1991;48:944-8.
30. Keller KJ, Cascio CS, Bergstrom DA, Butler JA, Iadarola P. Electroconvulsive shock and reserpine: effects on beta-adrenergic receptors in rat brain. J Neurochem 1981;37:830-6.
31. Kolbinger HM, Hoflich G, Hufnagel A, Moller HJ, Kasper S. Transcranial magnetic stimulation (TMS) in the treatment of major depression: a pilot study. Hum Psychopharmacol 1995;10:305-10.
32. Lerer B, Belmaker RH. Receptors and the mechanism of action of ECT. Biol Psychiatry 1982;17:497-511.
33. Lichtstein D, Dobkin J, Ebstein RP, Biederman J, Rimon R, Belmaker RH. GABA in the CSF of schizophrenic patients before and after neuroleptic treatment. Br J Psychiatry 1987;132:145-8.
34. McGarvey KA, Zis AP, Brown EE, Nomikos GG, Fibiger HC. ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment and stimulus intensity. Biol Psychiatry 1993;34:152-7.
35. Modigh K, Balldin J, Eriksson E, Granerus AK, Walinder J. Increased responssiveness of dopamine receptors after ECT: a review of experimental and clinical evidence. In: Lerer B, Weiner RD, Belmaker RH, eds. ECT: basic mechanisms. London: John Libbey, 1984:18-27.
36. Nimgaonkar VL, Heal DJ, Davies CL, Green AR, Studies on rat brain catecholamine synthesis and beta-adrenoceptor number following administration of electroconvulsive shock, desipramine and clenbuterol. J Neural Transm 1986;63:245-59.
37. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
38. Pascual-Leone A, Houser CM, Reese K, Shotland LI, Grafman J, Sato S, Valls-Sole J, Brasil-Neto JP, Wassermann EM, Cohen LG, Hallett M. Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalogr Clin Neurophysiol 1993;89:120-30.
39. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Beneficial effect of rapid-rate transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996;348:223-7.
40. Pascual-Leone A, Valls Sole J, Brasil Neto JP, Cammarota A, Grafman J, Hallet M. Akinesia in Parkinson's disease, part 2: effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology 1994b;44:892-8.
41. Pascual-Leone A, Valls Sole J, Brasil Neto JP, Cohen LG, Hallet M. Akinesia in Parkinson's disease, part 1: shortening of simple reaction time with focal, single-pulse TMS. Neurology 1994a;44:884-91.
42. Pfefferbaum A, Wenegrat B, Ford J, Roth WT, Koppell BS. Clinical application of the P3 component of event-related potentials: II dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol 1984;59:104-24.
43. Porsolt RD, Bertin A, Blavet N. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979;57:201-20.
44. Potter WZ, Rudorfer MV Electroconvulsive therapy: a modern medical procedure. N Engl J Med 1993;328:882-3.
45. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-8.
46. Sackeim HA, Decina P, Prohovnik I, Portnoy S, Kanzler M, Malitz S, Dosage, seizure threshold and the antidepressant efficacy of electroconvulsive therapy. Ann N Y Acad Sci 1986;462:398-410.
47. Sackeim HA, Prudig J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839-46.
48. Salmon RM, Miller HL, Delgado PL. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders. Int Clin Psychopharmacol Suppl 1993;2:41-6.
49. Stone EA. Stress and catecholamines. In: Friedhoff AJ, ed. Catecholamines and behavior. Vol 2. Neuropsychopharmacology. New York: Plenum Press, 1975:31-72.
50. Zis AP, Nomikos GG, Brown EE, Damsma G, Fibiger HC. Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology 1992;7:189-95.
51. Zis AP, Nomikos GG, Damsma G, Fibiger HC. In vivo neurochemical effects of electroconvulsive shock: studies by microdialysis in the rat striatum. Psychopharmacology 1991;103:343-50.